BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19362972)

  • 21. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic Waldenstrom's macroglobulinemia.
    Alexanian R; Weber D; Delasalle K; Cabanillas F; Dimopoulos M
    Semin Oncol; 2003 Apr; 30(2):206-10. PubMed ID: 12720137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Waldenström's macroglobulinemia.
    Dimopoulos MA; Anagnostopoulos A
    Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors.
    Owen RG; Barrans SL; Richards SJ; O'Connor SJ; Child JA; Parapia LA; Morgan GJ; Jack AS
    Am J Clin Pathol; 2001 Sep; 116(3):420-8. PubMed ID: 11554171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waldenström's macroglobulinemia: prognostic factors and recent therapeutic advances.
    Leblond V; Tournilhac O; Morel P
    Clin Exp Med; 2004 Apr; 3(4):187-98. PubMed ID: 15103509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct characteristics and new prognostic scoring system for Chinese patients with Waldenström macroglobulinemia.
    Yi S; Cui R; Li Z; An G; Qi J; Zou D; Zhang P; Chen H; Wang J; Chang H; Qiu L
    Chin Med J (Engl); 2014; 127(12):2327-31. PubMed ID: 24931251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence and survival of Waldenström's Macroglobulinaemia in South East England.
    Phekoo KJ; Jack RH; Davies E; Møller H; Schey SA;
    Leuk Res; 2008 Jan; 32(1):55-9. PubMed ID: 17416416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Waldenström macroglobulinaemia--the experience of one centre].
    Adam Z; Pour L; Krejcí M; Korístek Z; Navrátil M; Krivanová A; Zahradová L; Hájek R
    Vnitr Lek; 2009 Jan; 55(1):9-17. PubMed ID: 19227950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic cell transplantation for Waldenström macroglobulinemia.
    Bachanova V; Burns LJ
    Bone Marrow Transplant; 2012 Mar; 47(3):330-6. PubMed ID: 21572463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
    J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.
    Dimopoulos MA; Kastritis E; Delimpassi S; Zomas A; Kyrtsonis MC; Zervas K
    Haematologica; 2008 Sep; 93(9):1420-2. PubMed ID: 18641029
    [No Abstract]   [Full Text] [Related]  

  • 33. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostication of the high-risk WM patient.
    Kastritis E; Gavriatopoulou M; Kyrtsonis MC; Michael M; Hadjiharissi E; Symeonidis A; Michalis E; Repoussis P; Tsatalas K; Sioni A; Kartasis Z; Stefanoudaki E; Voulgarelis M; Delimpasi S; Gika D; Vervesou E; Konstantopoulos K; Kokkini G; Zomas A; Roussou P; Anagnostopoulos N; Economopoulos T; Terpos E; Zervas K; Dimopoulos MA
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):127-9. PubMed ID: 21454212
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
    Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
    [No Abstract]   [Full Text] [Related]  

  • 36. SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia.
    Poulain S; Ertault M; Leleu X; Coiteux V; Fernandes J; Stalnikiewicz L; Duthilleul P; Morel P
    Leuk Res; 2009 Sep; 33(9):1204-7. PubMed ID: 19394082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review.
    Buske C; Sadullah S; Kastritis E; Tedeschi A; García-Sanz R; Bolkun L; Leleu X; Willenbacher W; Hájek R; Minnema MC; Cheng M; Bilotti E; Graef T; Dimopoulos MA;
    Lancet Haematol; 2018 Jul; 5(7):e299-e309. PubMed ID: 29958569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
    J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
    Sagaster V; Kaufmann H; Odelga V; Ackermann J; Gisslinger H; Rabitsch W; Zojer N; Ludwig H; Nösslinger T; Zielinski C; Drach J
    Eur J Haematol; 2007 Mar; 78(3):227-34. PubMed ID: 17253972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.
    Anagnostopoulos A; Zervas K; Kyrtsonis M; Symeonidis A; Gika D; Bourantas K; Zomas A; Anagnostopoulos N; Pangalis G; Dimopoulos MA;
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):205-9. PubMed ID: 17229336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.